American Thoracic Society (ATS)

ATS Announces $500,000 COVID-19 Crisis Fund Support from AstraZeneca

3-Jun-2020 8:15 AM EDT, by American Thoracic Society (ATS)

June 3, 2020  –Today, the American Thoracic Society (ATS) announced a $500,000 donation from AstraZeneca to the ATS COVID-19 Crisis Fund, launched to support the Society’s all-encompassing efforts to fight COVID-19. The Crisis Fund will help clinicians and scientists develop and disseminate research, education and scientific recommendations to providers in the pulmonary and critical care communities, as well as to support other clinicians in need of expanding their skill set during this emergency.

As a membership society of leading pulmonary and critical care doctors, the ATS has held a critical role in the discourse on initiatives to counter the spread of the coronavirus and provide support to pulmonary and critical care specialists on the frontlines, who are treating patients diagnosed with COVID-19. As COVID-19 ravages individuals and medical infrastructures worldwide, the ATS is seeking industry support to fulfill its mission to the greatest extent possible.

“We are extremely grateful for AstraZeneca’s generosity,” said ATS President Juan C. Celedón, MD, DrPH.  “The COVID-19 Crisis Fund gives our members access to resources to help them collaborate, develop, and share the most up-to-date findings and treatments, to the benefit of patients worldwide. AstraZeneca’s commitment to our community is greatly appreciated during this critical fight against the COVID-19 pandemic.”

“AstraZeneca believes in the important role that ATS plays in helping to educate and support healthcare providers, and as a long-standing partner remains committed to putting patients first,” said Mina Makar, Senior Vice President, US Respiratory and Immunology, AstraZeneca. “The direct, immediate support we are providing to ATS will ensure that the pulmonary and critical care community has the resources, education and support it needs to battle COVID-19 – at a time when there is a significant burden on the healthcare community.”

It is the ATS’s hope that donations to the fund will motivate other industry groups to share their resources in helping to address the significant needs arising from the COVID-19 crisis.

For more information about making a donation to the ATS COVID-19 Crisis Fund, please contact the ATS Office of Development at dev@thoracic.org




Filters close

Showing results

110 of 2545
Newswise: Hackensack Meridian CDI has Struck a COVID-19 Research Collaboration with Merck
Released: 14-Jul-2020 10:00 AM EDT
Hackensack Meridian CDI has Struck a COVID-19 Research Collaboration with Merck
Hackensack Meridian Health

The CDI will work with Merck to identify candidate treatments for the still-spreading pandemic.

Released: 14-Jul-2020 9:00 AM EDT
COVID-19 pandemic could be learning opportunity for middle-grade students
Binghamton University, State University of New York

Educators could use the COVID-19 outbreak to help middle-schoolers better understand the world, according to new research from faculty at Binghamton University, State University of New York.

access_time Embargo lifts in 2 days
Embargo will expire: 14-Jul-2020 6:30 PM EDT Released to reporters: 14-Jul-2020 8:55 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Jul-2020 6:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Big Data Analytics Enables Scientists to Model COVID-19 Spread
Released: 14-Jul-2020 8:30 AM EDT
Big Data Analytics Enables Scientists to Model COVID-19 Spread
Florida Atlantic University

Researchers will use big data analytics techniques to develop computational models to predict the spread of COVID-19. They will utilize forward simulation from a given patient and the propagation of the infection into the community; and backward simulation tracing a number of verified infections to a possible patient “zero.” The project also will provide quick and automatic contact tracing and leverages the researchers’ prior experience in modeling Ebola spread.

Newswise: Keck Medicine of USC enrolling patients as part of international clinical trial to study antiviral drug as treatment for COVID-19
Released: 14-Jul-2020 8:05 AM EDT
Keck Medicine of USC enrolling patients as part of international clinical trial to study antiviral drug as treatment for COVID-19
Keck Medicine of USC

Keck Medicine of USC physicians are enrolling patients as part of an international clinical trial to evaluate the safety and efficacy of an antiviral drug, DAS181, as a possible treatment for hospitalized patients with severe COVID-19.

Newswise: Donate Blood to Save a Life
Released: 14-Jul-2020 8:00 AM EDT
Donate Blood to Save a Life
Rutgers Cancer Institute of New Jersey

Stay-at-home orders during the COVID-19 pandemic has resulted in an increased need for blood and platelets. Rutgers Cancer Institute expert shares why right now is an important time to donate blood to ensure a sufficient blood supply for patients in need.

Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.


Showing results

110 of 2545

close
1.03933